Correlation of serum magnesium with cardiovascular risk factors in maintenance hemodialysis patients - A cross-sectional study

Magnesium Research

Volumn 26, Issue 3, 2013, Pages 100-108

  Liu, Feng ^a   Zhang, Xintian ^a   Qi, Hualin ^a   Wang, Jun ^a   Wang, Min ^a   Zhang, Yingying ^a   Yan, Haidong ^a   Zhuang, Shougang ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BROWN UNIVERSITY   (United States)

Author keywords

Calcium phosphate metabolism; Cardiovascular disease; Hemodialysis; Hemodialysis efficiency; Inflammation; Intradialytic hypotension; Magnesium; Nutrition status

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; PHOSPHORUS; TRIACYLGLYCEROL;

ADULT; ARM CIRCUMFERENCE; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; HEMODIALYSIS; HUMAN; HYPERMAGNESEMIA; HYPOMAGNESEMIA; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PROTEIN INTAKE; SKINFOLD;

CALCIUM-PHOSPHATE METABOLISM; CARDIOVASCULAR DISEASE; HEMODIALYSIS; HEMODIALYSIS EFFICIENCY; INFLAMMATION; INTRADIALYTIC HYPOTENSION; MAGNESIUM; NUTRITION STATUS;

CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS;

EID: 84887282515     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2013.0344     Document Type: Article

References (30)

1. Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clin Asp Magnes 1985; 4: 226-44.
2. Wyskida K, Witkowicz J, Chudek J, Wie{ogonek}cek A. Daily magnesium intake and hypermagnesemia in hemodialysis patients with chronic kidney disease. J Ren Nutr 2012; 22: 19-26.
3. Spiegel DM. Magnesium in chronic kidney disease: unanswered questions. Blood Purif 2011; 31: 172-6.
4. Cunningham J, Rodriguez M, Messa P. Magnesium in chronic kidney disease stages 3 and 4 and in dialysis patients. Clin Kidney J 2012; 5(Supple1): i39-i51.
5. Navarro-González JF, Mora-Fernández C, García-Pérez J. Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Semin Dial 2009; 22: 37-44.
6. Kanbay M, Goldsmith D, Uyar ME, Turgut F, Covic A. Magnesium in chronic kidney disease: challenges and opportunities. Blood Purif 2010; 29: 280-92.
7. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-83.
8. KanbayM, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T, Acikel C, Vural A, Covic A. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol 2012; 36: 228-37.
9. Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 2008; 40: 1075-82.
10. Pakfetrat M, Malekmakan L, Roozbeh J, Haghpanah S. Magnesium and its relationship to C-reactive protein among hemodialysis patients. Magnes Res 2008; 21: 167-70.
11. Ansari MR, Maheshwari N, Shaikh MA, Laghari MS, Darshana, Lal K, Ahmed K. Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis. Saudi J Kidney Dis Transpl 2012; 23: 21-5.
12. Khatami MR, Mirchi E, Khazaeipour Z, Abdollahi A, Jahanmardi A. Association between serum magnesium and risk factors of cardiovascular disease in hemodialysis patients. Iran J Kidney Dis 2013; 7: 47-52.
13. Bringhurst FR, Demay MB, Krane SM, Kronenberg HM. Disorders of bone and mineral metabolism in health and disease. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al., eds. 17th ed. Harrisons, principles of internal medicine. United States: Mc Grow-Hill com 2008; 2365-77.
14. Chacko SA, Song Y, Nathan L, Tinker L, de Boer IH, Tylavsky F, Wallace R, Liu S. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 2010; 33: 304-10.
15. NKF-DOQI Clinical Practice Guidelines for Hemodialysis Adequacy v. Hemodialysis dose troubleshooting. Am J Kidney Dis 2001; 37: 542.
16. Nasir H, Baradaran A. Correlation of serum magnesium with dyslipedemia in maintenance hemodialysis patients. Acta Medica (Hradec Kralove) 2004; 47: 263-5.
17. Robles NR, Escola JM, Albarran L, Espada R, Cruz A. Correlation of serum magnesium and serum lipid levels in hemodialysis patients. Dial Transplant 1998; 27: 644-8.
18. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 2007; 458: 48-56.
19. King DE, Mainous AG, Geesey ME, Woolson RF. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr 2005; 24: 166-71.
20. Altura BM, Zhang A, Altura BT. Magnesium, hypertensive vascular diseases, and atherogenesis, subcellular compartmentation of Ca21 and Mg21 and vascular contractility. Miner Electrolyte Metab 1993; 19: 323-36.
21. Laurant P, Touyz RM. Physiological and pathophysiological role of magnesium in the cardiovascular system: Implications in hypertension. J Hypertens 2000; 18: 1177-91.
22. Krásniak A, Drozdz M, Pasowicz M, Chmiel G, Michałek M, Szumilak D, Podolec P, Klimeczek P, Konieczýnska M, Wicher-Muniak E, Tracz W, Khoa TN, Souberbielle JC, Drueke TB, Sulowicz W. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant 2007; 22: 515-21.
23. Altura BM, Altura BT, Gebrewold A, Ising H, Gunther T. Magnesium deficiency and hypertension: correlation between magnesium-deficient diets and microcirculatory changes in situ. Science 1984; 223: 1315-7.
24. Navarro-González JF, Mora-Fernández C, García-Pérez J. Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Semin Dial 2009; 22: 37-44.
25. Ari E, Kaya Y, Demir H, Asicioglu E, Keskin S. The correlation of serum trace elements and heavy metals with carotid artery atherosclerosis in maintenance hemodialysis patients. Biol Trace Elem Res 2011; 144: 351-9.
26. Kisters K, Gremmler B, Hausberg M. Magnesium and arterial stiffness. Hypertension 2006; 47: e3.
27. Tzanakis I, Virvidakis K, Tsomi A, Mantakas E, Girousis N, Karefyllakis N, Papadaki A, Kallivretakis N, Mountokalakis T. Intra-and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res 2004; 17: 102-8.
28. Tzanakis IP, Oreopoulos DG. Beneficial effects of magnesium in chronic renal failure: a foe no longer. Int Urol Nephrol 2009; 41: 363-71.
29. Baradaran A, Nasri H. Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis. Saudi J Kidney Dis Transpl 2006; 17: 344-50.
30. Hutchison AJ, Wilkie M. Use of magnesium as a drug in chronic kidney disease. Clin Kidney J 2012; (Supple1): i62-i70.